Join Our Sponsor, Abbvie, for a Lunch Symposium: Glecaprevir/Pibrentasvir (Mavyret): Case by Case
This sponsor-organized event is nor moderated or endorsed by the Florida Gastroenterologic Society.
Related Articles
Combination glecaprevir, pibrentasvir with ezetimibe prevents HCV in transplantation
LONDON — Combined glecaprevir and pibrentasvir with ezetimibe prevented hepatitis C infection among patients who received non-liver solid organ transplants with HCV viremic grafts, according…
Murphy Introduces Bipartisan Legislation to Protect Medicare for Physicians and Patients
In response to growing concerns over physician reimbursement cuts, Congressman Greg Murphy, M.D., has introduced the bipartisan Medicare Patient Access and Practice Stabilization Act (H.R.…
FGS Kicks Off Its All-New Webinar Series
This month marks the beginning of a new webinar series initiated and hosted by FGS President, Dr. Alison Schneider. November’s webinar will focus on HPB/Biliary…
2019 FGS Annual Meeting Wrap-Up
September 15, 2019 marked the conclusion of the 54th Florida Gastroenterologic Society’s Annual Meeting. Over 475 Gastroenterologists, Advanced Practice Providers, GI Nurses and Techs converged…
Universal HCV screening in pregnancy accelerates after 2020 screening guideline updates
Following updated hepatitis C virus screening recommendations issued in 2020, HCV screening in pregnancy accelerated across the country, according to a retrospective cohort study published…